ClinicalTrials.gg
Not yet recruitingNCT07940699Updated Nov 17, 2026

Carotid Decision Making

An interventional study of Decision Aid in Carotid Artery Stenoses and Carotid Artery Stenosis Asymptomatic, sponsored by Dartmouth-Hitchcock Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Supportive care

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 84 studies in Carotid Stenosis with a site in United States — 6 open to participants now, 13 under way, none of them phase 3. Carotid Stenosis · United States.

Planned enrollment
31st of 53
50 · median 69
Started
2026
with 1 other
No phase
29 of 84
4 open now
Primary completion
2028-05
later than 9 of 12 live
Registered
84th of 84
by date

Among the 84 studies in Carotid Stenosis with a site in United States, this one is the 31st largest by planned enrollment of the 53 interventional ones that give a count, is one of 2 that started in 2026, is one of 29 with no phase, reaches primary completion later than 9 of the 12 other live ones, and was the 84th registered.

Carotid Stenosis

368 studies on the registry are indexed under Carotid Stenosis; 87 are open to participants now.

Browse Carotid Stenosis studies →

Open to participants now

6 of the 84 studies in Carotid Stenosis with a site in United States are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 61 Carotid Stenosis studies recruiting now, 39 (64%) set no upper age limit and none (0%) stop at 75 or younger; 4 take children under 18; 4 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 84 studies in Carotid Stenosis with a site in United States, or all of them as a file.
02

Study summary

Carotid artery stenosis is a common cause of ischemic stroke in the U.S. and disproportionately affects older adults. Patients with carotid artery stenosis face a complex set of decisions when choosing a treatment strategy. Patients must choose among surveillance with medical therapy alone, versus medical therapy plus one of three different procedures. Each treatment option has different levels of evidence to support it, some of which are decades old. Each procedural option has different expected periprocedural courses, different recoveries, and different cardiovascular risks. This challenging decision is amplified among older adults, where decisional values are often different from younger patients traditionally studied in randomized or observational studies. A decision aid could assist patients and providers who are navigating this decision, but no decision aid currently exists that includes all the contemporary carotid artery stenosis treatment options. In addition, as of October 2023, participation in a shared decision-making conversation is a Medicare-mandated component of carotid stenosis care, with reimbursement for procedures predicated on the documentation of the conversation with the patient.

The objective of this project is to conduct a single arm open label trial to test the feasibility of using a paper-based decision aid for patients considering carotid revascularization. The investigators will conduct a feasibility trial using the decision aid on older adults who are considering carotid revascularization. The investigators will recruit 50 participants aged 65 or older from the vascular surgery clinic and administer the decision aid. The investigators will purposively sample at least 10 participants that are age 80 or older. Primary outcomes will center on feasibility, and secondary outcomes will center on decisional conflict and regret.

Read the detailed description

The primary outcomes of this single arm open label feasibility trial are focused on feasibility, and the secondary outcomes will provide data to inform a subsequent R01 study design.

Exposure: The decision aid

Setting: The investigators will sample newly referred and longitudinally treated patients from the Dartmouth Health Vascular Clinic who are being treated for carotid artery stenosis and who are considering carotid revascularization.

Sampling strategy: The investigators will enroll 50 patient-participants. The investigators will review the clinic schedules of the 18 providers each day in clinic and screen them for patients being seen for carotid artery stenosis. The investigators will then discuss with the providers in clinic that day whether any of the patients they are seeing may be considered for carotid revascularization and whether that respective patient would be appropriate for and have the capacity to utilize a decision aid. The investigators will purposively sample a minimum of 10 participants who are aged 80 and older to ensure adequate representation of this age group. Patients with carotid stenosis routinely have a high burden of comorbidities including hypertension, diabetes, coronary disease, kidney disease, and smoking. Patients treated in the Dartmouth Vascular Clinic are representative of this population and will allow us to sample a cohort with multiple comorbidities. Patients meeting the inclusion and exclusion criteria and felt to be appropriate for a decision aid per their treating provider will be approached in clinic to discuss the study.

Statistical analysis:

Outcome 1: The investigators will measure the mean and standard deviation of the time of the clinic visit. The investigators will calculate the visit time from the time of patient check in until the completion of the clinic visit, as assessed by a direct observer. The investigators will compare this to baseline time measurements recorded in the electronic health record for a random sample of 50 carotid stenosis patients meeting the same inclusion / exclusion criteria in the past 3 months.

Outcome 2: The investigators will conduct semi-structured interviews with 10 patients to follow up on the findings from the surveys above. These will be semi-structured interviews that are designed to assess whether the tradeoffs for each decision aid option were understood, and whether they felt that the decision aid helped them reach their choice. The interviews will be recorded and transcribed. The constant comparative method will be used to identify codes inductively. Two independent coders will analyze the data, and then codes will be discussed and data organized. Areas of disagreement will be resolved by consensus, or, if consensus is not possible, by a third independent reviewer. The investigators will organize the codes into key domains through data reduction and interpretation, paying particular attention to the frequency of specific ideas / codes mentioned by participants, and how many participants mentioned them.

The investigators will administer a similar survey to their treating providers within 1 week of the clinic visit. The results of the Likert surveys will be converted to a 5-point scale and the mean and median response will be computed with 95% confidence intervals. The investigators will additionally conduct semi-structured interviews with treating providers to determine feasibility of decision aid use in routine practice.

Secondary outcomes: The investigators will administer a validated decisional conflict scale and decisional regret scale before and after administration of the decision aid. The investigators will use the low literacy version to account for the high prevalence of low literacy in older adults. The investigators will analyze the results according to the validated methods for that survey and compare the before and after results. The investigators will additionally measure the actual treatment decision made by the patient and report this unadjusted. The investigators will finally measure knowledge-based questions that will be administered before and after patients are given the decision aid.

Sample size considerations: For outcome 1, given a sample size of 50 normally distributed outcomes, this will result in sample size with 95% confidence intervals with half widths of 0.32 standard deviation of the matched visit estimates of added time for increasing to 0.34, and 0.36 with 10% and 20% missing data. Similar results hold for the Likert survey in Outcome 3.

Potential pitfalls and alternative strategies: It is possible that it may not be known whether a patient would benefit from a decision aid until the patient receives an imaging study demonstrating the severity of the patient's carotid disease, which may occur just before the patient's clinic visit. Therefore, for patients who are scheduled for a clinic visit but do not have an imaging study, the investigators will ask the vascular laboratory (where the studies are conducted) to notify study personnel once the imaging study is completed.

03

Conditions studied

  • Carotid Artery Stenoses
  • Carotid Artery Stenosis Asymptomatic

Browse trials for

Keywords

  • carotid revascularization
  • decision aid
  • decision making
  • multicenter
  • RCT
  • carotid artery stenosis
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients seen in the outpatient clinic who are considering carotid revascularization versus medical therapy or who were admitted to the hospital and are considering elective carotid revascularization.

Exclusion criteria

Exclusion Criteria:

  • Patients who are considering urgent revascularization, those unable to provide using the Short Portable Mental Status Questionnaire or those unable to participate in follow-up interview or survey scales due to cognitive reasons.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Decision aid feasibility

    Single arm pilot feasibility study of using a decision aid for patients with asymptomatic carotid artery stenosis considering revascularization

    Other: Decision Aid

Interventions

  • OtherDecision Aid

    The decision aid is paper-based and includes pie charts of perioperative risks and incorporates patient values and preferences about autonomy of decision making.

06

What researchers measure

Primary outcomes

  1. Time to administer the decision aid

    Defined as time from clinic check-in until completion of the visit

    Time frame: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

  2. Understanding of the decision aid

    Measured by a knowledge survey

    Time frame: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

Secondary outcomes

  1. Decisional conflict

    Measured using the validated decisional conflict scale

    Time frame: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

  2. Decisional regret

    Measured using the validated decisional regret scale

    Time frame: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

  3. Actual treatment decision made

    What treatment the patient actually decided on

    Time frame: Assessed for up to 8 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Tinetti ME, Hashmi A, Ng H, Doyle M, Goto T, Esterson J, Naik AD, Dindo L, Li F. Patient Priorities-Aligned Care for Older Adults With Multiple Conditions: A Nonrandomized Controlled Trial. JAMA Netw Open. 2024 Jan 2;7(1):e2352666. doi: 10.1001/jamanetworkopen.2023.52666. PubMed 38261319 ↗
  • Fulmer T, Reuben DB, Auerbach J, Fick DM, Galambos C, Johnson KS. Actualizing Better Health And Health Care For Older Adults. Health Aff (Millwood). 2021 Feb;40(2):219-225. doi: 10.1377/hlthaff.2020.01470. Epub 2021 Jan 21. PubMed 33476185 ↗
  • Col NF, Solomon AJ, Springmann V, Garbin CP, Ionete C, Pbert L, Alvarez E, Tierman B, Hopson A, Kutz C, Berrios Morales I, Griffin C, Phillips G, Ngo LH. Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals. Med Decis Making. 2018 Jan;38(1):44-55. doi: 10.1177/0272989X17724434. Epub 2017 Aug 14. PubMed 28806143 ↗
  • Sarmiento I, Cockcroft A, Dion A, Belaid L, Silver H, Pizarro K, Pimentel J, Tratt E, Skerritt L, Ghadirian MZ, Gagnon-Dufresne MC, Andersson N. Fuzzy cognitive mapping in participatory research and decision making: a practice review. Arch Public Health. 2024 May 20;82(1):76. doi: 10.1186/s13690-024-01303-7. PubMed 38769567 ↗
  • Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5. PubMed 28402085 ↗
  • Silver B, Zaman IF, Ashraf K, Majed Y, Norwood EM, Schuh LA, Smith BJ, Smith RE, Schultz LR. A randomized trial of decision-making in asymptomatic carotid stenosis. Neurology. 2012 Jan 31;78(5):315-21. doi: 10.1212/WNL.0b013e31824528df. Epub 2012 Jan 4. PubMed 22218277 ↗
  • Scalia P, Schubbe DC, Lu ES, Durand MA, Frascara J, Noel G, O'Malley AJ, Elwyn G. Comparing the impact of an icon array versus a bar graph on preference and understanding of risk information: Results from an online, randomized study. PLoS One. 2021 Jul 23;16(7):e0253644. doi: 10.1371/journal.pone.0253644. eCollection 2021. PubMed 34297713 ↗
  • Scalia P, O'Malley AJ, Durand MA, Goodney PP, Elwyn G. Presenting time-based risks of stroke and death for Patients facing carotid stenosis treatment options: Patients prefer pie charts over icon arrays. Patient Educ Couns. 2019 Oct;102(10):1939-1944. doi: 10.1016/j.pec.2019.05.004. Epub 2019 May 9. PubMed 31101429 ↗
  • Jayasooriya GS, Shalhoub J, Thapar A, Davies AH. Patient preference survey in the management of asymptomatic carotid stenosis. J Vasc Surg. 2011 Jun;53(6):1466-72. doi: 10.1016/j.jvs.2011.01.065. Epub 2011 Apr 8. PubMed 21477967 ↗
  • Knoepke CE, Allen LA, Kramer DB, Matlock DD. Medicare Mandates for Shared Decision Making in Cardiovascular Device Placement. Circ Cardiovasc Qual Outcomes. 2019 Jul;12(7):e004899. doi: 10.1161/CIRCOUTCOMES.119.004899. Epub 2019 Jul 3. No abstract available. PubMed 31266371 ↗
  • Fowler FJ Jr, Barry MJ, Sepucha KR, Moulton BW. Let's Require Patients to Review a High-quality Decision Aid Before Receiving Important Tests and Treatments. Med Care. 2021 Jan;59(1):1-5. doi: 10.1097/MLR.0000000000001440. No abstract available. PubMed 33136712 ↗
  • Leinweber KA, Columbo JA, Kang R, Trooboff SW, Goodney PP. A Review of Decision Aids for Patients Considering More Than One Type of Invasive Treatment. J Surg Res. 2019 Mar;235:350-366. doi: 10.1016/j.jss.2018.09.017. Epub 2018 Nov 13. PubMed 30691817 ↗
  • McDermott KM, White M, Bose S, Tan LT, Columbo JA, Siracuse JJ, Hicks CW. Racial Differences in Adoption and Outcomes of Transcarotid Artery Revascularization among High-Risk Adults with Carotid Artery Stenosis. Ann Vasc Surg. 2025 Apr;113:370-381. doi: 10.1016/j.avsg.2024.09.036. Epub 2024 Oct 2. PubMed 39362465 ↗
  • Columbo JA, Martinez-Camblor P, Stone DH, Goodney PP, O'Malley AJ. Procedural Safety Comparison Between Transcarotid Artery Revascularization, Carotid Endarterectomy, and Carotid Stenting: Perioperative and 1-Year Rates of Stroke or Death. J Am Heart Assoc. 2022 Oct 4;11(19):e024964. doi: 10.1161/JAHA.121.024964. Epub 2022 Sep 29. PubMed 36172943 ↗
  • Columbo JA, Martinez-Camblor P, O'Malley AJ, Stone DH, Kashyap VS, Powell RJ, Schermerhorn ML, Malas M, Nolan BW, Goodney PP. Association of Adoption of Transcarotid Artery Revascularization With Center-Level Perioperative Outcomes. JAMA Netw Open. 2021 Feb 1;4(2):e2037885. doi: 10.1001/jamanetworkopen.2020.37885. PubMed 33616666 ↗
  • Columbo JA, Stone DH, Martinez-Camblor P, Goodney PP, O'Malley AJ. Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice. Circ Cardiovasc Interv. 2023 Sep;16(9):e012805. doi: 10.1161/CIRCINTERVENTIONS.122.012805. Epub 2023 Sep 19. PubMed 37725675 ↗
  • Cole TS, Mezher AW, Catapano JS, Godzik J, Baranoski JF, Nakaji P, Albuquerque FC, Lawton MT, Little AS, Ducruet AF. Nationwide Trends in Carotid Endarterectomy and Carotid Artery Stenting in the Post-CREST Era. Stroke. 2020 Feb;51(2):579-587. doi: 10.1161/STROKEAHA.119.027388. Epub 2019 Dec 18. PubMed 31847750 ↗
  • Lichtman JH, Jones MR, Leifheit EC, Sheffet AJ, Howard G, Lal BK, Howard VJ, Wang Y, Curtis J, Brott TG. Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014. JAMA. 2017 Sep 19;318(11):1035-1046. doi: 10.1001/jama.2017.12882. PubMed 28975306 ↗
  • Columbo JA, Stone DH. What Is the Role of Transcarotid Artery Revascularization in the Treatment of Carotid Stenosis? NEJM Evid. 2023 Feb;2(2):EVIDtt2200178. doi: 10.1056/EVIDtt2200178. Epub 2023 Jan 24. PubMed 38320038 ↗
  • Sibbritt D, Bayes J, Peng W, Adams J. Demographic factors effect stoke-related healthcare utilisation among Australian stroke survivors. Sci Rep. 2024 Sep 11;14(1):21241. doi: 10.1038/s41598-024-72092-w. PubMed 39261541 ↗
  • Levy SA, Pedowitz E, Stein LK, Dhamoon MS. Healthcare Utilization for Stroke Patients at the End of Life: Nationally Representative Data. J Stroke Cerebrovasc Dis. 2021 Oct;30(10):106008. doi: 10.1016/j.jstrokecerebrovasdis.2021.106008. Epub 2021 Jul 27. PubMed 34330019 ↗
  • Kamal N, Rogers E, Stang J, Mann B, Butcher KS, Rempel J, Jeerakathil T, Shuaib A, Goyal M, Menon BK, Demchuk AM, Hill MD. One-Year Healthcare Utilization for Patients That Received Endovascular Treatment Compared With Control. Stroke. 2019 Jul;50(7):1883-1886. doi: 10.1161/STROKEAHA.119.024870. Epub 2019 Jun 3. PubMed 31154945 ↗
  • Ahmad FB, Cisewski JA, Anderson RN. Leading Causes of Death in the US, 2019-2023. JAMA. 2024 Sep 24;332(12):957-958. doi: 10.1001/jama.2024.15563. PubMed 39116093 ↗
  • Grotta JC. Clinical practice. Carotid stenosis. N Engl J Med. 2013 Sep 19;369(12):1143-50. doi: 10.1056/NEJMcp1214999. No abstract available. PubMed 24047063 ↗
  • Krafcik BM, Jarmel IA, Beach JM, Suckow BD, Stableford JA, Stone DH, Goodney PP, Columbo JA. Decision aids for patients with carotid stenosis. J Vasc Surg. 2024 Mar;79(3):704-707. doi: 10.1016/j.jvs.2023.10.050. Epub 2023 Nov 3. PubMed 37923023 ↗
  • Weinstein JN, Clay K, Morgan TS. Informed patient choice: patient-centered valuing of surgical risks and benefits. Health Aff (Millwood). 2007 May-Jun;26(3):726-30. doi: 10.1377/hlthaff.26.3.726. PubMed 17485750 ↗
  • O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, Entwistle VA, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner D. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001431. doi: 10.1002/14651858.CD001431.pub2. PubMed 19588325 ↗
  • Garcia-Retamero R, Okan Y, Cokely ET. Using visual aids to improve communication of risks about health: a review. ScientificWorldJournal. 2012;2012:562637. doi: 10.1100/2012/562637. Epub 2012 May 2. PubMed 22629146 ↗
  • Garcia-Retamero R, Hoffrage U. Visual representation of statistical information improves diagnostic inferences in doctors and their patients. Soc Sci Med. 2013 Apr;83:27-33. doi: 10.1016/j.socscimed.2013.01.034. Epub 2013 Feb 8. PubMed 23465201 ↗
  • Eid MA, Barry MJ, Tang GL, Henke PK, Johanning JM, Tzeng E, Scali ST, Stone DH, Suckow BD, Lee ES, Arya S, Brooke BS, Nelson PR, Spangler EL, Murebee L, Dosluoglu HH, Raffetto JD, Kougais P, Brewster LP, Alabi O, Dardik A, Halpern VJ, O'Connell JB, Ihnat DM, Zhou W, Sirovich BE, Metha K, Moore KO, Voorhees A, Goodney PP; Preferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Study Team. Effect of a Decision Aid on Agreement Between Patient Preferences and Repair Type for Abdominal Aortic Aneurysm: A Randomized Clinical Trial. JAMA Surg. 2022 Sep 1;157(9):e222935. doi: 10.1001/jamasurg.2022.2935. Epub 2022 Sep 14. PubMed 35947375 ↗
  • Columbo JA, Kang R, Spangler EL, Newhall K, Brooke BS, Dosluoglu H, Lee ES, Raffetto JD, Henke PK, Tang GS, Mureebe L, Kougias P, Johanning J, Arya S, Scali ST, Stone DH, Suckow BD, Orion K, Halpern V, O'Connell J, Inhat D, Nelson P, Tzeng E, Zhou W, Barry M, Sirovich B, Goodney PP; PROVE-AAA Study Team. Design of the PReferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Trial. Ann Vasc Surg. 2020 May;65:247-253. doi: 10.1016/j.avsg.2019.02.034. Epub 2019 May 8. PubMed 31075459 ↗
  • Krafcik BM, Stone DH, Scali ST, Cai M, Jarmel IA, Hicks CW, Goodney PP, Columbo JA. Patient decision-making in the era of transcarotid artery revascularization. J Vasc Surg. 2024 Jul;80(1):125-135.e7. doi: 10.1016/j.jvs.2024.02.035. Epub 2024 Mar 5. PubMed 38447624 ↗
  • Nejim B, Alshwaily W, Dakour-Aridi H, Locham S, Goodney P, Malas MB. Age modifies the efficacy and safety of carotid artery revascularization procedures. J Vasc Surg. 2019 May;69(5):1490-1503.e3. doi: 10.1016/j.jvs.2018.07.062. PubMed 31010514 ↗
  • Miller MT, Comerota AJ, Tzilinis A, Daoud Y, Hammerling J. Carotid endarterectomy in octogenarians: does increased age indicate "high risk?". J Vasc Surg. 2005 Feb;41(2):231-7. doi: 10.1016/j.jvs.2004.11.021. PubMed 15768004 ↗
  • Kibrik P, Stonko DP, Alsheekh A, Holscher C, Zarkowsky D, Abularrage CJ, Hicks CW. Association of carotid revascularization approach with perioperative outcomes based on symptom status and degree of stenosis among octogenarians. J Vasc Surg. 2022 Sep;76(3):769-777.e2. doi: 10.1016/j.jvs.2022.04.027. Epub 2022 May 25. PubMed 35643202 ↗
  • De Rango P, Lenti M, Simonte G, Cieri E, Giordano G, Caso V, Isernia G, Cao P. No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg. 2012 Sep;44(3):252-9. doi: 10.1016/j.ejvs.2012.06.006. Epub 2012 Jul 21. PubMed 22819739 ↗
  • Malas MB, Dakour-Aridi H, Kashyap VS, Eldrup-Jorgensen J, Wang GJ, Motaganahalli RL, Cronenwett JL, Schermerhorn ML. TransCarotid Revascularization With Dynamic Flow Reversal Versus Carotid Endarterectomy in the Vascular Quality Initiative Surveillance Project. Ann Surg. 2022 Aug 1;276(2):398-403. doi: 10.1097/SLA.0000000000004496. Epub 2020 Sep 15. PubMed 32941280 ↗
  • Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R, Eckstein HH, Henao S, LaMuraglia G, Stoner MC, Melton J, Massop D, Hanover T, Titus J, Moore WS, Rodriguez-Carvajal R, Malas MB, Arko FR 3rd, Pierce D, Anain P, Oskin T; ROADSTER 2 Investigators*. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease. Stroke. 2020 Sep;51(9):2620-2629. doi: 10.1161/STROKEAHA.120.030550. Epub 2020 Aug 19. PubMed 32811386 ↗
  • Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL, Nolan BW, Kashyap VS, Wang GJ, Motaganahalli RL, Malas MB. Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting With Stroke or Death Among Patients With Carotid Artery Stenosis. JAMA. 2019 Dec 17;322(23):2313-2322. doi: 10.1001/jama.2019.18441. PubMed 31846015 ↗
  • Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, Wechsler L, Jaff MR, Gray W; ACT I Investigators. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. N Engl J Med. 2016 Mar 17;374(11):1011-20. doi: 10.1056/NEJMoa1515706. Epub 2016 Feb 17. PubMed 26886419 ↗
  • Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, Moore WS, Hill MD, Mantese VA, Clark WM, Timaran CH, Heck D, Leimgruber PP, Sheffet AJ, Howard VJ, Chaturvedi S, Lal BK, Voeks JH, Hobson RW 2nd; CREST Investigators. Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med. 2016 Mar 17;374(11):1021-31. doi: 10.1056/NEJMoa1505215. Epub 2016 Feb 18. PubMed 26890472 ↗
  • Chang RW, Tucker LY, Rothenberg KA, Lancaster E, Faruqi RM, Kuang HC, Flint AC, Avins AL, Nguyen-Huynh MN. Incidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention. JAMA. 2022 May 24;327(20):1974-1982. doi: 10.1001/jama.2022.4835. PubMed 35608581 ↗
  • Howard DPJ, Gaziano L, Rothwell PM; Oxford Vascular Study. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2021 Mar;20(3):193-202. doi: 10.1016/S1474-4422(20)30484-1. PubMed 33609477 ↗
  • Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009 Oct;40(10):e573-83. doi: 10.1161/STROKEAHA.109.556068. Epub 2009 Aug 20. PubMed 19696421 ↗
  • Muller MD, Lyrer P, Brown MM, Bonati LH. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020 Feb 25;2(2):CD000515. doi: 10.1002/14651858.CD000515.pub5. PubMed 32096559 ↗
  • Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2017 Jun 7;6(6):CD001081. doi: 10.1002/14651858.CD001081.pub3. PubMed 28590505 ↗
  • Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001923. doi: 10.1002/14651858.CD001923.pub2. PubMed 16235289 ↗
  • Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ; American College of Cardiology Foundation; American Stroke Association; American Association of Neurological Surgeons; American College of Radiology; American Society of Neuroradiology; Congress of Neurological Surgeons; Society of Atherosclerosis Imaging and Prevention; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of NeuroInterventional Surgery; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation. 2011 Jul 26;124(4):489-532. doi: 10.1161/CIR.0b013e31820d8d78. Epub 2011 Jan 31. No abstract available. PubMed 21282505 ↗
  • AbuRahma AF, Avgerinos ED, Chang RW, Darling RC 3rd, Duncan AA, Forbes TL, Malas MB, Murad MH, Perler BA, Powell RJ, Rockman CB, Zhou W. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2022 Jan;75(1S):4S-22S. doi: 10.1016/j.jvs.2021.04.073. Epub 2021 Jun 19. PubMed 34153348 ↗
  • de Weerd M, Greving JP, de Jong AW, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke. 2009 Apr;40(4):1105-13. doi: 10.1161/STROKEAHA.108.532218. Epub 2009 Feb 26. PubMed 19246704 ↗
  • Woo SY, Joh JH, Han SA, Park HC. Prevalence and risk factors for atherosclerotic carotid stenosis and plaque: A population-based screening study. Medicine (Baltimore). 2017 Jan;96(4):e5999. doi: 10.1097/MD.0000000000005999. PubMed 28121957 ↗
  • Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke. 2000 May;31(5):1062-8. doi: 10.1161/01.str.31.5.1062. PubMed 10797166 ↗
  • Linder SK, Swank PR, Vernon SW, Mullen PD, Morgan RO, Volk RJ. Validity of a low literacy version of the Decisional Conflict Scale. Patient Educ Couns. 2011 Dec;85(3):521-4. doi: 10.1016/j.pec.2010.12.012. Epub 2011 Feb 5. PubMed 21300518 ↗
  • Columbo JA, Suckow BD, Griffin CL, Cronenwett JL, Goodney PP, Lukovits TG, Zwolak RM, Fillinger MF. Carotid endarterectomy should not be based on consensus statement duplex velocity criteria. J Vasc Surg. 2017 Apr;65(4):1029-1038.e1. doi: 10.1016/j.jvs.2016.11.028. Epub 2017 Feb 9. PubMed 28190714 ↗
  • Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975 Oct;23(10):433-41. doi: 10.1111/j.1532-5415.1975.tb00927.x. PubMed 1159263 ↗
  • Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D. Validation of a decision regret scale. Med Decis Making. 2003 Jul-Aug;23(4):281-92. doi: 10.1177/0272989X03256005. PubMed 12926578 ↗
  • O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995 Jan-Mar;15(1):25-30. doi: 10.1177/0272989X9501500105. PubMed 7898294 ↗

Individual participant data

Plan to share: No — Will not share individual patient data due to confidentiality.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2028, 18 months later.

Of 51 non-industry interventional studies with no phase under Carotid Stenosis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 50. This study's planned 18 months is below that.

Counting every sponsor, half of 62 studies reached it within 27 months; a quarter within 19 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 17, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
May 15, 2028
CompletionEst.
May 15, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07940699
Responsible party
Jesse.A.Columbo (Research Project Leader, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
May 15, 2028 (estimated)
Completion
May 15, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Jesse Columbo, MD
Contact
Jesse.A.Columbo@hitchcock.org
603-650-8193

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion